Philips recalls 5,400 HeartStart defibrillators
This article was originally published in Clinica
Philips has recalled 5,400 of its HeartStart FR2+ automated external defibrillators (AEDs) due to a memory chip failure which could render the device inoperable. The devices were manufactured between May 2007 and January 2008, and are distributed by Philips and Laerdal Medical, a UK-based device distributor. The devices are used to treat cardiac arrest with high-current/low energy therapy. Philips said a “small number” of the devices were faulty, and there have been no reports of injuries related to the malfunction.
You may also be interested in...
Alere’s professional diagnostics business helped the firm record overall revenue growth in the fourth quarter of 2010, offsetting a fall in influenza-based sales in North America.
Integra LifeSciences has gained exclusive worldwide rights from Stout Medical to develop and commercialise an expandable interbody fusion device.
Gen-Probe recently launched its Panther automated molecular diagnostics system in Europe with the aim of bringing another dimension to its product portfolio. Joseph Harvey met the firm’s CEO, Carl Hull, at the launch of the product in Frankfurt to find how high the firm has set its sights in the molecular diagnostics sector and how it is going to achieve its goals